
Figure 2. Comparison of GenScript PK kit and conventional RUO quantitative kit

Figure 3. Comparison of GenScript ADA kit and conventional RUO quantitative kit
Figure 1. Development process of antibody drug
GenScript PK/ADA kits are developed and validated according to FDA and NMPA regulations, and accuracy of kits is evaluated according to the guidance document CLSI EP05-A3 to ensure its accuracy and reliability. GenScript PK/ADA kits can satisfy the needs of PK and ADA research during preclinical and clinical research.
Figure 2. Comparison of GenScript PK kit and conventional RUO quantitative kit
Figure 3. Comparison of GenScript ADA kit and conventional RUO quantitative kit
Figure 4. Pharmacokinetic ELISA kit
Figure 5. Immunogenicity ELISA kit (Bridging ELISA)
Figure 6. ADC Pharmacokinetics ELISA Kit
Figure 7. Ideal standard curve
Set 6 concentration points, standard curve range 160-2.5 ng/mL (MRD (Minimum Required Dilution) = concentration before 1:100 dilution), sensitivity: 5 ng/mL.
Figure 8. High selectivity
The dashed lines in the figure represent the critical lines of 80% and 120% precision.
HQC (High Quality Control) level selectivity: The precision of 100% blank individual matrices from different sources is 80.5% ~ 105%, and the precision is 0.9% ~ 6.4%.
LLOQ (Lower Limit of Quantification) level selectivity: The precision of 90% blank individual matrices from different sources is 95.8% ~ 116.8%, and the precision is 1.0% ~ 10.6%.
The blank individual matrices from different sources: The signal values of 10 blank individual matrices from different sources are all lower than the LLOQ signal value.
Figure 9. High specificity
Human IgG4 (1600 ng/mL) was added. The accuracy of Pembrolizumab at ULOQ and LLOQ levels is 85.6% ~ 113.8%, and the precision is 2% ~ 5.1%.
Human IgG4 (160 ng/mL) was added. The accuracy of Pembrolizumab at ULOQ and LLOQ levels is 89.1% ~ 111.9%, and the precision is 0.4% ~ 0.5%.
Table 1. Intra-Assay and Inter-Assay precision of L00968
Quality control |
Expected Pembrolizumab (ng/ml) | Intra-Assay (n=10) | Inter-Assay (n=30) | ||||
---|---|---|---|---|---|---|---|
Measured Pembrolizumab (ng/ml) | CV % | Accuracy % | Measured Pembrolizumab (ng/ml) | CV % | Accuracy % | ||
P1 | 120 | 102.41 | 6.92 | 85.34 | 105.08 | 2.65 | 87.57 |
P2 | 30 | 29.58 | 3.88 | 98.61 | 31.00 | 0.83 | 103.33 |
P3 | 15 | 16.64 | 2.99 | 110.96 | 17.77 | 2.71 | 118.49 |
Precision of L00968: Intra-Assay CV% <7%, Inter-Assay CV% <3%.
Table 2. Hook effect analysis
Pembrolizumab (ng/ml) | Absorbance (OD 450/630 nm) | CV % | ||
---|---|---|---|---|
Duplicate 1 | Duplicate 2 | Average | ||
15,000 | 5.845 | 5.323 | 5.584 | 6.60 |
1,500 | 5.881 | 5.611 | 5.746 | 3.33 |
750 | 5.505 | 5.583 | 5.544 | 0.99 |
The precision of the concentrations of three samples above ULOQ level is not affected by the hook effect (signal suppression caused by high concentration samples).
Table 3. Dilution linearity analysis
Dilution Factor | Expected Pembrolizumab (ng/ml) | Measured Pembrolizumab (ng/ml) | CV % | Accuracy % |
---|---|---|---|---|
1:2,000 | 7.5 | 8.496 | 0.28 | 113.28 |
1:1,000 | 15 | 17.215 | 2.27 | 114.77 |
1:100 | 15 | 15.406 | 1.21 | 102.71 |
1:50 | 15 | 15.597 | 2.92 | 103.98 |
Dilute the standard product by 4 different dilution ratios, after dilution factor correction, the accuracy of each diluted standard product is 102.7% ~114.8%, and the precision is 0.28% ~ 2.9%.
Figure 10. Rigorous positive control antibody screening
The sensitivity of 4 antibodies is validated to be greater than 20 ng/mL through screening experiments, and results show that all 4 antibodies can be used as positive control antibodies by further validation experiments. Based on the screening and validation results, the antibody with the highest sensitivity is selected as the final positive control antibody for ELISA kit.
Figure 11. Ideal standard curve
Set 6 concentration points, standard curve range 50-0.78 ng/mL (MRD = concentration before 1:100 dilution), sensitivity: 1.56 ng/mL.
Figure 12. MRD analysis
When MRD=1:5, the signal value of the sample prepared with biological matrix is closest to the signal value of the sample prepared with sample diluent.
Figure 13. High selectivity
The dashed line in the figure is the screening critical value line.
LQC (Low Quality Control) level selectivity: The precision of 87% blank individual matrices from different sources is 0.2% ~ 8.5%, and signal value is not lower than the screening critical value.
Blank level selectivity: The precision of 87% blank individual matrices from different sources is 0.6% ~ 14.3%, and signal value is lower than the screening critical value.
Figure 14. Hook effect analysis
As the concentration of Anti-Pembrolizumab increases, the signal value increases. The signal value of high-concentration samples is higher than the signal value of the high point of the standard curve, and there is no significant signal suppression phenomenon. No hook effect is observed within the tested concentration range.
Table 4. Intra-Assay and Inter-Assay precision of L00971
Samples | Expected Anti-Pembrolizumab (ng/mL) | Intra-Assay (n=10) | Inter-Assay (n=30) | ||||
---|---|---|---|---|---|---|---|
Measured Anti-Pembrolizumab (ng/mL) | CV % | Accuracy % | Measured Anti-Pembrolizumab (ng/mL) | CV % | Accuracy % | ||
P1 | 50 | 49.27 | 3.26 | 98.54 | 50.96 | 3.51 | 102.07 |
P2 | 7.5 | 7.75 | 4.27 | 103.37 | 8.22 | 4.17 | 110.32 |
P3 | 2.5 | 2.15 | 7.27 | 85.81 | 2.39 | 8.07 | 95.40 |
Precision of L00971: Intra-Assay CV% <8%, Inter-Assay CV% <9%.
Cat. No. | Product Name | Quantity | Price | Order |
---|---|---|---|---|
L00968
|
Pembrolizumab Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
L00969
|
Bevacizumab Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
L00970
|
Trastuzumab Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
L00972
|
DXd ADC Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
L00978
|
Pertuzumab Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
L00991
|
MMAE ADC Pharmacokinetic ELISA Kit |
|
$498.00 96 Tests |
|
Cat. No. | Product Name | Quantity | Price | Order |
---|---|---|---|---|
L00971
|
Pembrolizumab Immunogenicity Kit (Bridging ELISA) |
|
$498.00 96 Tests |
|
L00979
|
Pertuzumab Immunogenicity Kit (Bridging ELISA) |
|
$498.00 96 Tests |
|
L01007
|
Trastuzumab Immunogenicity Kit (Bridging ELISA) |
|
$498.00 96 Tests |
|
Cat. No. | Product Name | Quantity | Price | Order |
---|---|---|---|---|
A02217
|
DXd Antibody (39F4), mAb, Mouse |
|
$160.00 40 μg |
|
A02223
|
DM1 Antibody (15L2), mAb, Mouse |
|
$160.00 40 μg |
|
A02224
|
MMAE Antibody (69F7), mAb, Mouse |
|
$160.00 40 μg |
|
A02225
|
MMAF Antibody (11B8), mAb, Mouse |
|
$160.00 40 μg |
|
Anti-Abatacept/Orencia (Target: CTLA-4-Fc)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02262-40 | Anti-Abatacept Antibody (CT.F3), mAb, Mouse | - | ELISA, PK study | A02262-40 (C) - A02263-40 (D)A02263-40 (C) - A02262-40 (D) |
|
A02263-40 | Anti-Abatacept Antibody (CT.E8), mAb, Mouse | - | ELISA, PK study |
|
Anti-Certolizumab pegol/Cimzia (Target: TNF alpha)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02268 | MonoRab™ Anti-Certolizumab Antibody (15H11), mAb, Rabbit | Inhibitory | ELISA, PK study | A02268-40 (C) - A02269-40 (D) |
|
A02269 | MonoRab™ Anti-Certolizumab Antibody (12A3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Ixekizumab/Taltz (Target: IL-17A)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02264-40 | MonoRab™ Anti-Ixekizumab Antibody (19F6), mAb, Rabbit | Inhibitory | ELISA, PK study | A02264-40 (C) - A02265-40 (D) |
|
A02265-40 | MonoRab™ Anti-Ixekizumab Antibody (29B12), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Ocrelizumab/Ocrevus (Target: CD20)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02258-40 | MonoRab™ Anti-Ocrelizumab Antibody (12G10), mAb, Rabbit | Inhibitory | ELISA, PK study | A02258-40 (C) - A02259-40 (D) |
|
A02259-40 | MonoRab™ Anti-Ocrelizumab Antibody (15E7), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Teclistamab/Tecvayli (Target: BCMAxCD3)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02253-40 | Anti-Teclistamab Antibody (10H1), mAb, Mouse | Non-inhibitory for CD3 | ELISA, PK study | A02253-40 (C) - A02254-40 (D) |
|
A02254-40 | Anti-Teclistamab Antibody (36D3), mAb, Mouse | Inhibitory for CD3 | ELISA, PK study |
|
Anti-Zolbetuximab/IMAB362 (Target: Claudin 18.2)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02260-40 | Anti-Zolbetuximab Antibody (34E11), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02260-40 (C) - A02261-40 (D) |
|
A02261-40 | Anti-Zolbetuximab Antibody (9C9), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Evolocumab/Repatha (Target: PCSK9)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02293-40 | MonoRab™ Anti-Evolocumab Antibody (39B8), mAb, Rabbit | Inhibitory | ELISA, PK study | A02293-40 (C) - A02294-40 (D) |
|
A02294-40 | MonoRab™ Anti-Evolocumab Antibody (36A11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Lecanemab/Leqembi (Target: amyloid β)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02270-40 | MonoRab™ Anti-Lecanemab Antibody (44G1), mAb, Rabbit | Inhibitory | ELISA, PK study | A02270-40 (C) - A02271-40 (D) |
|
A02271-40 | MonoRab™ Anti-Lecanemab Antibody (4F2), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Mosunetuzumab/Cevostamab (Target: CD3)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02290-40 | MonoRab™ Anti-Mosunetuzumab Antibody (4G6), mAb, Rabbit | Inhibitory for CD3 | ELISA, PK study | A02293-40 (C) - A02294-40 (D) |
|
A02291-40 | MonoRab™ Anti-Mosunetuzumab Antibody (38A10), mAb, Rabbit | Inhibitory for CD3 | ELISA, PK study |
|
|
A02292-40 | MonoRab™ Anti-Mosunetuzumab Antibody (10D5), mAb, Rabbit | Non-inhibitory for CD3 | ELISA, PK study | / |
|
Anti-Adalimumab/Humira (Target: TNF alpha)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01954-40 | Anti-Adalimumab Antibody (15C7), mAb, Mouse | Inhibitory | ELISA, PK study | A01954-40 (C) - A01955-40 (D) A01954-40 (C) - A01956-40 (D) |
|
A01955-40 | Anti-Adalimumab Antibody (3C2), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01956-40 | Anti-Adalimumab Antibody (3C2) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01921-40 | MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit | Inhibitory | ELISA, PK study | A01921-40 (C) - A01922-40 (D) |
|
A01922-40 | MonoRab™ Anti-Adalimumab Antibody (134D5), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
A01923-40 | MonoRab™ Anti-Adalimumab Antibody (196F3), mAb, Rabbit | Non-inhibitory | ELISA, PK study | - |
|
A01886-40 | Anti-Adalimumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Atezolizumab/Tecentriq (Target: PD-L1)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01948-40 | Anti-Atezolizumab Antibody (10G9), mAb, Mouse | Inhibitory | ELISA, PK study |
A01948-40 (C) - A01949-40 (D) A01948-40 (C) - A01950-40 (D) |
|
A01949-40 | Anti-Atezolizumab Antibody (6B12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01950-40 | Anti-Atezolizumab Antibody (6B12) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01984-40 | MonoRab™ Anti-Atezolizumab Antibody (55D8) mAb, Rabbit | Inhibitory | ELISA, PK study |
A01984-40 (C) - A01985-40 (D) A01984-40 (C) - A01986-40 (D) |
|
A01985-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
A01986-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
Anti-Avelumab/Bavencio (Target: PD-L1)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02121-40 | Anti-Avelumab Antibody (12H7), mAb, Mouse | Inhibitory | ELISA, PK study | A02121-40 (C) - A02120-40 (D) |
|
A02120-40 | Anti-Avelumab Antibody (12G9), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Bevacizumab/Avastin (Target: VEGF-A)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01975-40 | Anti-Bevacizumab Antibody (4H1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01975-40 (C) - A01976-40 (D) A01975-40 (C) - A01977-40 (D) |
|
A01976-40 | Anti-Bevacizumab Antibody (6C3), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A01977-40 | Anti-Bevacizumab Antibody (6C3)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A02185-40 | Anti-Bevacizumab Antibody (11C1), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02185-40 (C) - A01962-40 (D) A02185-40 (C) - A01896-40 (D) |
|
A01895-40 | MonoRab™ Anti-Bevacizumab Antibody (30E1), mAb, Rabbit | Non-inhibitory | ELISA, PK study | A01895-40 (C) - A01962-40 (D) A01895-40 (C) - A01896-40 (D) |
|
A01962-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
A01896-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
A01887-40 | Anti-Bevacizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Cetuximab/Erbitux (Target: EGF Receptor)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01939-40 | Anti-Cetuximab Antibody (20H1), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01939-40 (C) - A01938-40 (D) |
|
A01938-40 | Anti-Cetuximab Antibody (18D5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A01991-40 | MonoRab™ Anti-Cetuximab Antibody (69H10), mAb, Rabbit | Inhibitory | ELISA, PK study | A01991-40 (C) - A01992-40 (D) |
|
A01992-40 | MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Daratumumab/Darzalex (Target: CD38)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01996-40 | Anti-Daratumumab Antibody (11F2), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01996-40 (C) - A01997-40 (D) |
|
A01997-40 | Anti-Daratumumab Antibody (6A3), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A01998-40 | Anti-Daratumumab Antibody (9A6), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
A02009-40 | MonoRab™ Anti-Daratumumab(139B10), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
Anti-Denosumab/Prolia (Target: RANK Ligand)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02229-40 | Anti-Denosumab Antibody (3B1), mAb, Mouse | Inhibitory | ELISA, PK study | A02229-40 (C) - A02230-40 (D) |
|
A02230-40 | Anti-Denosumab Antibody (16F2), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A02101-40 | Anti-Denosumab Antibody (2H7), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02101-40 (C) - A02102-40 (D) |
|
A02102-40 | Anti-Denosumab Antibody (9A10), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Dupilumab/Dupixent (Target: IL-4Rα)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02098-40 | Anti-Dupilumab Antibody (6C9), mAb, Mouse | Inhibitory | ELISA, PK study | A02098-40 (C) - A02097-40 (D) |
|
A02097-40 | Anti-Dupilumab Antibody (2D5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Durvalumab/Imfinzi (Target: CD274)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02031-40 | Anti-Durvalumab Antibody (15D6), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
Anti-Eculizumab/Soliris (Target: Complement protein C5)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02115-40 | Anti-Eculizumab Antibody (4F6), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02115-40 (C) - A02116-40 (D) |
|
A02116-40 | Anti-Eculizumab Antibody(13F5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Etanercept/Enbrel (Target: TNF alpha)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02114-40 | Anti-Etanercept Antibody (4H5), mAb, Mouse | Inhibitory | ELISA, PK study | A02114-40 (C) - A02113-40 (D) |
|
A02113-40 | Anti-Etanercept Antibody (4H1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
Anti-Golimumab/Simponi (Target: TNF alpha)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02093-40 | Anti-Golimumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Infliximab/Remicade (Target: TNF alpha)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02040-40 | Anti-Infliximab Antibody (27A4) , mAb, Mouse | Non-inhibitory | ELISA, PK study | A02040-40 (C) - A02041-40 (D) |
|
A02041-40 | Anti-Infliximab Antibody (23H5) , mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A02061-40 | Anti-Infliximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Ipilimumab/Yervoy (Target: CTLA-4)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01859-40 | Anti-Ipilimumab Antibody(26B6H7D9), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01859-40 (C) - A01961-40 (D) A01859-40 (C) - A01858-40 (D) |
|
A01961-40 | Anti-Ipilimumab Antibody (4H6), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01858-40 | Anti-Ipilimumab Antibody (4H6)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
Anti-Nivolumab/Opdivo (Target: PD-1)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01847-40 | Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01847-40 (C) - A01965-40 (D) A01847-40 (C) - A01848-40 (D) |
|
A01965-40 | Anti-Nivolumab Antibody (6G5), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01848-40 | Anti-Nivolumab Antibody(6G5)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01987-40 | MonoRab™ Anti-Nivolumab Antibody (33H4), mAb, Rabbit | Inhibitory | ELISA, PK study |
A01987-40 (C) - A01988-40 (D) A01987-40 (C) - A01989-40 (D) |
|
A01988-40 | MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
A01989-40 | MonoRab™ Anti-Nivolumab Antibody (40F11)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
A01990-40 | MonoRab™ Anti-Nivolumab Antibody (47F6), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
A01931-40 | Anti-Nivolumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Obinutuzumab/Gazyva (Target: CD20)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01945-40 | Anti-Obinutuzumab Antibody (18H8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01945-40 (C) - A01946-40 (D) A01945-40 (C) - A01947-40 (D) |
|
A01946-40 | Anti-Obinutuzumab Antibody (16B7), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01947-40 | Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01966-40 | MonoRab™ Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01966-40 (C) - A01967-40 (D) A01966-40 (C) - A01968-40 (D) |
|
A01967-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
|
|
A01968-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
A01933-40 | Anti-Obinutuzumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Omalizumab/Xolair (Target: Human IgE)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02095-40 | Anti-Omalizumab Antibody (10G3), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02095-40 (C) - A02094-40 (D) |
|
A02094-40 | Anti-Omalizumab Antibody (15B12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A02096-40 | Anti-Omalizumab Antibody (7G11), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
Anti-Palivizumab/Synagis (Target: RSV F)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02112-40 | Anti-Palivizumab Antibody (7B3), mAb, Mouse | Inhibitory | ELISA, PK study | A02112-40 (C) - A02111-40 (D) |
|
A02111-40 | Anti-Palivizumab Antibody (2F12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A02064-40 | Anti-Palivizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Panitumumab/Vectibix (Target: EGF Receptor)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02100-40 | Anti-Panitumumab Antibody (9G12), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02100-40 (C) - A02099-40 (D) |
|
A02099-40 | Anti-Panitumumab Antibody (2E7), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A02063-40 | Anti-Panitumumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Pembrolizumab/Keytruda (Target: PD-1)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01844-40 | Anti-Pembrolizumab Antibody(1D6E10), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
|
A01845-40 | Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse | - | ELISA, PK study | - |
|
A02008-40 | MonoRab™ Anti-Pembrolizumab Antibody (94B9), mAb, Rabbit | Inhibitory | ELISA, PK study | A02008-40 (C) - A02007-40 (D) |
|
A02007-40 | MonoRab™ Anti-Pembrolizumab Antibody (47E5), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
A01960-40 | MonoRab™ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
A01853-40 | MonoRab™ Anti-Pembrolizumab Antibody(90G12)[Biotin], mAb, Rabbit | - | ELISA, PK study | - |
|
A01846-40 | Anti-Pembrolizumab Antibody, pAb, Rabbit | - | ELISA,Immunogenicity assay | - |
|
Anti-Pembrolizumab/Keytruda PK ELISA Kit
Cat. No. | Product Name | Application | Order |
---|---|---|---|
L00968 | Pembrolizumab Pharmacokinetic ELISA Kit | GenScript’s Pembrolizumab Pharmacokinetic ELISA Kit is designed to quantify Pembrolizumab in serum and plasma with high specificity and sensitivity. The precision, accuracy, dilution linearity, specificity, selectivity, stability and hook effect of the kit were evaluated and validated according to ICH M10 and the FDA bioanalytical method validation guidance for industry and are all acceptable. The kit can be used for the quantification of whole Pembrolizumab and its biosimilars during drug research and development, and also for the detection of single-stranded variable fragments (scFv) of Pembrolizumab. |
|
Anti-Pertuzumab/Perjeta (Target: HER2)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02150-40 | Anti-Pertuzumab Antibody (1A3), mAb, Mouse | Inhibitory | ELISA, PK study | A02150-40 (C) - A02151-40 (D) |
|
A02151-40 | Anti-Pertuzumab Antibody (11H4), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A02208-40 | Anti-Pertuzumab Antibody (7H7), mAb, Mouse | Inhibitory | ELISA, PK study | A02150-40 (C) - A02208-40 (D) |
|
A02209-40 | Anti-Pertuzumab Antibody (16E2), mAb, Mouse | Inhibitory | ELISA, PK study | A02209-40 (C) - A02151-40 (D) |
|
A02220-40 | Anti-Pertuzumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Ranibizumab/Lucentis (Target: VEGF-A)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02035-40 | Anti-Ranibizumab Antibody (6C3), mAb, Mouse | Inhibitory | ELISA, PK study | A02035-40 (C) - A02036-40 (D) |
|
A02036-40 | Anti-Ranibizumab Antibody (10D12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A02037-40 | Anti-Ranibizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Rituximab/Rituxan (Target: CD20)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01969-40 | Anti-Rituximab Antibody (6C1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01969-40 (C) - A01970-40 (D) A01969-40 (C) - A01971-40 (D) |
|
A01970-40 | Anti-Rituximab Antibody (17B6), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A01971-40 | Anti-Rituximab Antibody (17B6)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01942-40 | MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01942-40 (C) - A01943-40 (D) A01942-40 (C) - A01944-40 (D) |
|
A01943-40 | MonoRab™ Anti-Rituximab Antibody (194D7), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
|
|
A01944-40 | MonoRab™ Anti-Rituximab Antibody (194D7)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
A01918-40 | Anti-Rituximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Sarilumab/Kevzara (Target: IL-6 Receptor)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02042-40 | Anti-Sarilumab Antibody (26B10) , mAb, Mouse | Inhibitory | ELISA, PK study | A02042-40 (C) - A02043-40 (D) |
|
A02043-40 | Anti-Sarilumab Antibody (23H12) , mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A02044-40 | Anti-Sarilumab Antibody (20F5), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
|
A02122-40 | Anti-Sarilumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Secukinumab/Cosentyx (Target: IL-17A)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02152-40 | Anti-Secukinumab Antibody (22G7), mAb, Mouse | Inhibitory | ELISA, PK study | A02152-40 (C) - A02153-40 (D) |
|
A02153-40 | Anti-Secukinumab Antibody (23E11), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Tocilizumab/Actemra (Target: IL-6 Receptor)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A01978-40 | Anti-Tocilizumab Antibody (14B10), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01978-40 (C) - A01979-40 (D) A01978-40 (C) - A01980-40 (D) |
|
A01979-40 | Anti-Tocilizumab Antibody (6C10), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
A01980-40 | Anti-Tocilizumab Antibody (6C10)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
A01932-40 | Anti-Tocilizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Trastuzumab/Herceptin (Target: HER2)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02032-40 | Anti-Trastuzumab Antibody (11C4), mAb, Mouse | - | ELISA, PK study | A02032-40 (C) - A02033-40 (D) |
|
A02033-40 | Anti-Trastuzumab Antibody (15H2), mAb, Mouse | - | ELISA, PK study |
|
Anti-Ustekinumab/Stelara (Target: IL-12 & IL-23)
Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
---|---|---|---|---|---|
A02118-40 | Anti-Ustekinumab Antibody (9A5), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02118-40 (C) - A02117-40 (D) |
|
A02117-40 | Anti-Ustekinumab Antibody (5F9), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
A02119-40 | Anti-Ustekinumab Antibody (11E3), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
A02123-40 | Anti-Ustekinumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Help you better explore the process of drug metabolism and the impact of drug immune reactions
Free Download